HIGHLIGHTS
- who: Jiayou Zhang et al. from the National Engineering Technology Research Center for Combined Vaccines, Wuhan, China have published the research work: The Epidemiology of Influenza and the Associated Vaccines Development in China: A Review, in the Journal: Vaccines 2022, 1873 of /2022/
- what: The main reasons for the differences in influenza vaccine coverage predictions from different researchers may be the effect of the increased influenza vaccine coverage in 2009 and differences in statistical methods.
- how: In 2019 the Wuhan Institute of Biological Products conducted a phase III clinical trial of the quadrivalent . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.